Research Paper Volume 16, Issue 15 pp 11513—11534
S100A9, as a potential predictor of prognosis and immunotherapy response for GBM, promotes the malignant progression of GBM cells and migration of M2 macrophages
Figure 9. Exploring the expression and distribution of S100A9 in two sets of GBM scRNA-seq data. (A) Cell clusters were identified in GBM cells and displayed in Uniform Manifold Approximation and Projection (UMAP). (B) UMAP plots of different cell types in GBM. (C) Expression and distribution of S100A9 in different types of cells.